TrademarkDir
NEUROCANNOL
DEAD

Serial Number

79318781

Owner

CDA Health Pty Ltd

Filing Date

Jun 10, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

NEUROCANNOL Trademark

Serial Number: 79318781

NEUROCANNOL is a trademark filed by CDA Health Pty Ltd on June 10, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

CDA Health Pty Ltd (3 trademarks)

C/- Stone Group Lawyers,

Entity Type: 82

Trademark Details

Filing Date

June 10, 2021

Registration Date

Not Registered

Goods & Services

Medical marijuana; pharmaceutical preparations; pharmaceutical preparations and substances for medical purposes; medicine; pharmaceutical preparations and substances for the treatment of cardiovascular diseases and conditions; herbal extracts for medicinal purposes; herbal preparations for medical purposes; medicinal oils; transdermal patches for administering pharmaceuticals; smoking herbs for medical purposes; preparations for the relief of pain; pharmaceutical preparations for the treatment of eye diseases and conditions; analgesics; topical dermatological products for medical purposes; topical pharmaceutical preparations; compounds for treating cancer; pharmaceutical preparations and substances for the treatment of depression, anxiety and related mood disorders; nutritional supplements; nutraceutical preparations for therapeutic or medical purposes; anti-inflammatory preparations; herbal preparations for use in medicine

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Apr 2, 2026 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 6, 2023 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Oct 17, 2023 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 17, 2023 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 20, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 1, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 1, 2023 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Oct 17, 2022 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Oct 17, 2022 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 17, 2022 ABN2
REFUSAL PROCESSED BY IB
Apr 24, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 1, 2022 RFCS
REFUSAL PROCESSED BY MPU
Apr 1, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 6, 2022 RFCR
NON-FINAL ACTION WRITTEN
Mar 5, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 2, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 4, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 31, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 26, 2021 REPR

Related Trademarks

More from this Owner

ISCHEMICANN

ISCHEMICANN

ALLEVICANN

ALLEVICANN